Literature DB >> 26708220

ANRIL regulates the proliferation of human colorectal cancer cells in both two- and three-dimensional culture.

Madoka Naemura1, Toshiyuki Tsunoda2, Yasutoshi Inoue1, Haruna Okamoto1, Senji Shirasawa2, Yojiro Kotake3,4.   

Abstract

ANRIL is a long noncoding RNA transcribed from the INK4 locus that encodes three tumor suppressor genes, p15, p16, and ARF. Previous studies demonstrated that ANRIL represses p15 and p16, which positively regulate the pRB pathway, leading to repression of cellular senescence of human normal fibroblasts. However, the role of ANRIL in cancer cell proliferation is less well understood. Here we report that ANRIL is involved in the proliferation of colorectal cancer HCT116 cells in two- and three-dimensional culture. Silencing ANRIL by both transfection with small interfering RNA and retrovirally produced small hairpin RNA reduced HCT116 cell proliferation in both two- and three-dimensional culture. HCT116 cells depleted for ANRIL were arrested in the S phase of cell cycle. Notably, silencing ANRIL did not result in the activation of expression of the INK4 locus. These results suggest that ANRIL positively regulates the proliferation of HCT116 cells in two- and three-dimensional culture in a p15/p16-pRB pathway-independent manner.

Entities:  

Keywords:  ANRIL; Cell cycle; Colorectal cancer; Long noncoding RNA; p15; p16

Mesh:

Substances:

Year:  2015        PMID: 26708220     DOI: 10.1007/s11010-015-2618-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

1.  CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC.

Authors:  Ada Congrains; Kei Kamide; Tomohiro Katsuya; Osamu Yasuda; Ryousuke Oguro; Koichi Yamamoto; Mitsuru Ohishi; Hiromi Rakugi
Journal:  Biochem Biophys Res Commun       Date:  2012-02-20       Impact factor: 3.575

Review 2.  Long noncoding RNAs: functional surprises from the RNA world.

Authors:  Jeremy E Wilusz; Hongjae Sunwoo; David L Spector
Journal:  Genes Dev       Date:  2009-07-01       Impact factor: 11.361

Review 3.  Long non-coding RNAs involved in cancer development and cell fate determination.

Authors:  Masatoshi Kitagawa; Yojiro Kotake; Tatsuya Ohhata
Journal:  Curr Drug Targets       Date:  2012-12       Impact factor: 3.465

4.  Role of the INK4a locus in tumor suppression and cell mortality.

Authors:  M Serrano; H Lee; L Chin; C Cordon-Cardo; D Beach; R A DePinho
Journal:  Cell       Date:  1996-04-05       Impact factor: 41.582

5.  Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene.

Authors:  Y Kotake; T Nakagawa; K Kitagawa; S Suzuki; N Liu; M Kitagawa; Y Xiong
Journal:  Oncogene       Date:  2010-12-13       Impact factor: 9.867

6.  The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

Authors:  F J Stott; S Bates; M C James; B B McConnell; M Starborg; S Brookes; I Palmero; K Ryan; E Hara; K H Vousden; G Peters
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

7.  Altered growth of human colon cancer cell lines disrupted at activated Ki-ras.

Authors:  S Shirasawa; M Furuse; N Yokoyama; T Sasazuki
Journal:  Science       Date:  1993-04-02       Impact factor: 47.728

Review 8.  Cell cycle regulation by long non-coding RNAs.

Authors:  Masatoshi Kitagawa; Kyoko Kitagawa; Yojiro Kotake; Hiroyuki Niida; Tatsuya Ohhata
Journal:  Cell Mol Life Sci       Date:  2013-07-24       Impact factor: 9.261

9.  Inhibition of phosphodiesterase-4 (PDE4) activity triggers luminal apoptosis and AKT dephosphorylation in a 3-D colonic-crypt model.

Authors:  Toshiyuki Tsunoda; Takeharu Ota; Takahiro Fujimoto; Keiko Doi; Yoko Tanaka; Yasuhiro Yoshida; Masahiro Ogawa; Hiroshi Matsuzaki; Masato Hamabashiri; Darren R Tyson; Masahide Kuroki; Shingo Miyamoto; Senji Shirasawa
Journal:  Mol Cancer       Date:  2012-07-25       Impact factor: 27.401

10.  Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a.

Authors:  Er-bao Zhang; Rong Kong; Dan-dan Yin; Liang-hui You; Ming Sun; Liang Han; Tong-peng Xu; Rui Xia; Jin-song Yang; Wei De; Jin fei Chen
Journal:  Oncotarget       Date:  2014-04-30
View more
  11 in total

Review 1.  Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis.

Authors:  Jie-Shan Chi; Jian-Zhou Li; Jing-Jing Jia; Ting Zhang; Xiao-Ma Liu; Li Yi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

Review 2.  Long non-coding RNAs: a rising biotarget in colorectal cancer.

Authors:  Jian Luo; Jian Qu; Dong-Kai Wu; Zhi-Li Lu; Yue-Sheng Sun; Qiang Qu
Journal:  Oncotarget       Date:  2017-03-28

Review 3.  LncRNAs: the bridge linking RNA and colorectal cancer.

Authors:  Yanfei Yang; Linjie Zhao; Lingzi Lei; Wayne Bond Lau; Bonnie Lau; Qilian Yang; Xiaobing Le; Huiliang Yang; Chenlu Wang; Zhongyue Luo; Yu Xuan; Yi Chen; Xiangbing Deng; Lian Xu; Min Feng; Tao Yi; Xia Zhao; Yuquan Wei; Shengtao Zhou
Journal:  Oncotarget       Date:  2017-02-14

4.  LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells.

Authors:  Zhen Wei Zou; Charlie Ma; Lorraine Medoro; Lili Chen; Bin Wang; Roohi Gupta; Ting Liu; Xian Zi Yang; Tian Tian Chen; Ruo Zhen Wang; Wen Jie Zhang; Pin Dong Li
Journal:  Oncotarget       Date:  2016-09-20

5.  Long non-coding RNA ANRIL is associated with a poor prognosis of osteosarcoma and promotes tumorigenesis via PI3K/Akt pathway.

Authors:  Guangyang Yu; Gang Liu; Dongtang Yuan; Jian Dai; Yin Cui; Xiaoming Tang
Journal:  J Bone Oncol       Date:  2018-02-13       Impact factor: 4.072

6.  A novel long noncoding RNA linc00460 up-regulated by CBP/P300 promotes carcinogenesis in esophageal squamous cell carcinoma.

Authors:  Yan Liang; Yuanyuan Wu; Xuedan Chen; Shixin Zhang; Kai Wang; Xingying Guan; Kang Yang; Juan Li; Yun Bai
Journal:  Biosci Rep       Date:  2017-10-17       Impact factor: 3.840

Review 7.  Diagnostic and prognostic potential of tissue and circulating long non-coding RNAs in colorectal tumors.

Authors:  Orsolya Galamb; Barbara K Barták; Alexandra Kalmár; Zsófia B Nagy; Krisztina A Szigeti; Zsolt Tulassay; Peter Igaz; Béla Molnár
Journal:  World J Gastroenterol       Date:  2019-09-14       Impact factor: 5.742

8.  Characterization of novel LncRNA P14AS as a protector of ANRIL through AUF1 binding in human cells.

Authors:  Wanru Ma; Juanli Qiao; Jing Zhou; Liankun Gu; Dajun Deng
Journal:  Mol Cancer       Date:  2020-02-27       Impact factor: 27.401

9.  Upregulating the Expression of LncRNA ANRIL Promotes Osteogenesis via the miR-7-5p/IGF-1R Axis in the Inflamed Periodontal Ligament Stem Cells.

Authors:  Minxia Bian; Yan Yu; Yuzhi Li; Zhou Zhou; Xiao Wu; Xiaying Ye; Jinhua Yu
Journal:  Front Cell Dev Biol       Date:  2021-02-22

10.  Circular ANRIL isoforms switch from repressors to activators of p15/CDKN2B expression during RAF1 oncogene-induced senescence.

Authors:  Lisa Muniz; Sandra Lazorthes; Maxime Delmas; Julien Ouvrard; Marion Aguirrebengoa; Didier Trouche; Estelle Nicolas
Journal:  RNA Biol       Date:  2020-09-29       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.